Startups
Biotech startup Lantern Pharma's IPO yields $26 million for its cancer drug development
A Dallas biotechnology startup will hire more cancer researchers, biologists and artificial intelligence developers with the $26 million it raised in an …
To Read More, Please Visit Source
